These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. Müller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K. J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701 [Abstract] [Full Text] [Related]
4. To bee or not to be? T-cell responses to bee venom PLA2 in relation to anaphylaxis and immunotherapy. McHugh SM. Clin Exp Allergy; 1997 Sep; 27(9):986-90. PubMed ID: 9678827 [No Abstract] [Full Text] [Related]
5. Mapping human T cell epitopes on phospholipase A2: the major bee-venom allergen. Dhillon M, Roberts C, Nunn T, Kuo M. J Allergy Clin Immunol; 1992 Jul; 90(1):42-51. PubMed ID: 1378459 [Abstract] [Full Text] [Related]
6. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. Fellrath JM, Kettner A, Dufour N, Frigerio C, Schneeberger D, Leimgruber A, Corradin G, Spertini F. J Allergy Clin Immunol; 2003 Apr; 111(4):854-61. PubMed ID: 12704369 [Abstract] [Full Text] [Related]
8. Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis. von Garnier C, Astori M, Kettner A, Dufour N, Heusser C, Corradin G, Spertini F. Eur J Immunol; 2000 Jun; 30(6):1638-45. PubMed ID: 10898500 [Abstract] [Full Text] [Related]
10. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Müller U, Blaser K. J Clin Invest; 1996 Oct 01; 98(7):1676-83. PubMed ID: 8833918 [Abstract] [Full Text] [Related]
12. The frequency of phospholipase A2 binding of basophilic granulocytes does not decrease during bee-venom-specific immunotherapy. Irsch J, König C, Löhndorf A, Tesch H, Krieg T, Merk H, Radbruch A, Hunzelmann N. Allergy; 1999 Jul 01; 54(7):742-7. PubMed ID: 10442531 [Abstract] [Full Text] [Related]
13. Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. Astori M, von Garnier C, Kettner A, Dufour N, Corradin G, Spertini F. J Immunol; 2000 Sep 15; 165(6):3497-505. PubMed ID: 10975871 [Abstract] [Full Text] [Related]
17. Epitope peptides and immunotherapy. Tanabe S. Curr Protein Pept Sci; 2007 Feb 15; 8(1):109-18. PubMed ID: 17305564 [Abstract] [Full Text] [Related]
18. Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor. Mori A, Thomas P, Tagaya Y, Iijima H, Grey H, Ishizaka K. Int Immunol; 1993 Aug 15; 5(8):833-42. PubMed ID: 7691164 [Abstract] [Full Text] [Related]
19. The murine (H-2k) T-cell epitopes of bee venom phospholipase A2 Lie outside the active site of the enzyme. Implications with respect to a paracrine activation of Th2 cells for an IgE antibody response. Specht C, Kölsch E. Int Arch Allergy Immunol; 1997 Mar 15; 112(3):226-30. PubMed ID: 9066507 [Abstract] [Full Text] [Related]